PRA Health Sciences, Inc. Deferred Revenue Recognized
PRA Health Sciences, Inc. reported Deferred Revenue Recognized of $359.40 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-04-29
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for the quarter ending 2021-03-31 was $359.40M, a 16.80% increase year-over-year.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for the quarter ending 2020-03-31 was $307.70M, a 17.85% increase year-over-year.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $261.10M, a 13.28% increase year-over-year.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $230.50M.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for fiscal 2020 was $476.40M, a 15.32% increase from fiscal 2019.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for fiscal 2019 was $413.10M, a 5.06% increase from fiscal 2018.
- PRA Health Sciences, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was $393.20M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2021-03-31 | $359.40M 10-Q · filed 2021-04-29 | |||
| 2020-12-31 | $476.40M 10-K · filed 2021-02-24 | |||
| 2020-09-30 | $455.20M 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $414.30M 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | $307.70M 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $413.10M 10-K · filed 2021-02-24 | |||
| 2019-09-30 | $398.40M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $363.20M 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $261.10M 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | $393.20M 10-K · filed 2020-02-21 | |||
| 2018-09-30 | $382.50M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | $373.20M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $230.50M 10-Q · filed 2019-05-02 |